NASDAQ: KURA - Kura Oncology, Inc.

Altı ay boyunca karlılık: -63.11%
Temettü getirisi: 0.00%
Sektör: Healthcare

Promosyon programı Kura Oncology, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında Kura Oncology, Inc.

Kura Oncology, Inc., биофармацевтическая компания клинической стадии, разрабатывает лекарства для лечения рака в Соединенных Штатах. Его портфель состоит из кандидатов на низкомолекулярные продукты, которые нацелены на рак.

daha fazla ayrıntı
Ведущими кандидатами на продукты компании являются типифарниб, пероральный биодоступный ингибитор фарнезилтрансферазы, который проходит фазу II клинических испытаний для лечения солидных опухолей и гематологических показаний; и KO-539, низкомолекулярный ингибитор менин-лизин-K-специфического белок-белкового взаимодействия метилтрансферазы 2A для лечения генетически определенных подмножеств острых лейкозов, включая острый миелоидный лейкоз и острый лимфобластный лейкоз. Kura Oncology, Inc. сотрудничает с Novartis для оценки комбинации типифарниба и алпелисиба у пациентов с плоскоклеточным раком головы и шеи, опухоли которых имеют гиперэкспрессию HRAS или мутацию и/или амплификацию PIK3CA. Компания была основана в 2014 году и имеет штаб-квартиру в Сан-Диего, штат Калифорния.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2015-09-22
ISIN US50127T1097
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://kuraoncology.com
Цена ао 7.77
Günlük fiyat değişimi: 0% (7.77)
Haftalık fiyat değişimi: -4.66% (8.15)
Aylık fiyat değişimi: 0% (7.77)
3 ayda fiyat değişimi: -30.44% (11.17)
Altı ayda fiyat değişimi: -63.11% (21.06)
Yıllık fiyat değişimi: -63.14% (21.08)
3 yılda fiyat değişimi: -54.24% (16.98)
5 yılda fiyat değişimi: -37.19% (12.37)
10 yılda fiyat değişimi: 0% (7.77)
Yılbaşından bu yana fiyat değişimi: -10.79% (8.71)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 0 0
P/BV 2.52 6
P/E 0 0
EV/EBITDA -5.96 0
Toplam: 3

Yeterlik

İsim Anlam Seviye
ROA, % -34 0
ROE, % -38.42 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.0657 10
Toplam: 8.4

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 0 0
karlılık Ebitda, % 163.67 10
karlılık EPS, % 38.03 5
Toplam: 7
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Suvretta Capital Management, LLC 7 9.28
Blackrock Inc. 7 9.06
EcoR1 Capital, LLC 6 7.62
Deerfield Management Company, L.P. (Series C) 5 7.1
BVF Inc. 5 6.28
State Street Corporation 4 5.51
Vanguard Group Inc 4 5.34
Avoro Capital Advisors LLC 4 5.05
Paradigm Biocapital Advisors LP 3 4.12
Holocene Advisors, LP 2 3.2

ETF Paylaşmak, % Yıllık karlılık, % Temettüler, %
Range Cancer Therapeutics ETF 1.26015 47.24 0.11955
Virtus LifeSci Biotech Clinical Trials ETF 0.76958 63.04 0.33
Invesco Dorsey Wright SmallCap Momentum ETF 0.34292 33.91 0.61241
Direxion Daily S&P Biotech Bull 3x Shares 0.21268 4067.92 0.25924
Future Tech ETF 0.15482 426.34 0.8416
Principal Healthcare Innovators ETF 0.15482 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.15468 28.58 0.8565
Fidelity Small-Mid Multifactor ETF 0.11582 32.31 1.59943
iShares Russell 2000 Growth ETF 0.11243 38.04 0.6026
Vanguard Russell 2000 Growth ETF 0.11 23.05 0.60264
ProShares Ultra Nasdaq Biotechnology 0.10254 51.7 0.85651
Nuveen ESG Small-Cap ETF 0.08804 13.91 1.41019
Vanguard U.S. Momentum Factor ETF 0.08 30.05 1.05834
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.07301 24.75 1.59225
Vanguard Russell 2000 ETF 0.06 17.16 1.48801
iShares ESG Aware MSCI USA Small-Cap ETF 0.05021 18.09 1.49366
iShares Morningstar Small-Cap Value ETF 0.04876 201.65 2.50476
iShares Morningstar Small Cap Value ETF 0.04876 26.7 2.50476
Schwab U.S. Small-Cap ETF 0.04247 17.47 1.51433
ProShares UltraPro Russell2000 0.03282 89.82 1.47873
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.03223 31.36 1.41955
Avantis U.S Small Cap Equity ETF 0.02451 27.77 1.68271
iShares Morningstar Small-Cap ETF 0.02369 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.02369 391.25 1.60498
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.01698 17.58 1.75869
Fidelity MSCI Health Care Index ETF 0.0144 3 1.46057
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00952 21.94 1.69572
ProShares Hedge Replication ETF 0.00895 5.92 1.47892
Dimensional U.S. Core Equity 2 ETF 0.00869 30.76 1.47098
Humankind US Stock ETF 0.00743 18.81 1.99919
Avantis Responsible U.S. Equity ETF 0.00729 26.78 1.45257
Avantis U.S. Equity ETF 0.00459 23.04 1.59151
Schwab U.S. Broad Market ETF 0.00314 24.86 1.43354
Dimensional US Core Equity Market ETF 0.00309 30.98 1.40618
iShares Russell 3000 ETF 0.00236 24.83 1.43482
Dimensional U.S. Equity ETF 0.00173 31.53 1.3557
Vanguard Russell 3000 ETF 0 31.87 1.43817



Süpervizör İş unvanı Ödeme Doğum yılı
Dr. Troy Edward Wilson J.D., Ph.D. Chairman, CEO & President 1.06M 1969 (56 yıllar)
Ms. Kathleen Ford Chief Operating Officer 754.24k 1947 (78 yıllar)
Dr. Stephen Dale M.D. Chief Medical Officer 684.41k 1972 (53 yıl)
Mr. Thomas Doyle Senior Vice President of Finance & Accounting N/A 1971 (54 yıl)
Mr. Pete De Spain Executive Vice President of Investor Relations & Corporate Communications N/A
Ms. Teresa Brophy Bair Esq., J.D. Chief Legal Officer & Corporate Secretary N/A 1971 (54 yıl)
Dr. Roger Bakale Ph.D. Senior Vice President of Manufacturing & Supply Chain N/A
Ms. Maureen Clancy M.B.A. VP and Global Head of Program Leadership & Project Management N/A
Dr. Mollie Leoni M.D. Executive Vice President of Clinical Development N/A
Mr. Brian T. Powl M.B.A., M.S. Chief Commercial Officer N/A 1974 (51 yıl)

Adres: United States, San Diego. CA, 12730 High Bluff Drive - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://kuraoncology.com